N. Ullrich

D. Zurakowski, G. Heidary, N. Ullrich, 2017, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.

Michael Fisher, A. Stemmer-Rachamimov, B. Korf, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children.

K. Kapur, L. Goumnerova, N. Ullrich, 2019, Neurosurgery.

Transverse myelitis after therapy for primitive neuroectodermal tumors.

S. Pomeroy, L. Goumnerova, M. Kieran, 2006, Pediatric neurology.

Psychological distress, functional dependence and neurologic morbidity among adult survivors of childhood cancer treated with CNS-directed therapies

Elizabeth M. Wells, G. Armstrong, K. Krull, 2016 .

Long-Term Outcome of 4,040 Children Diagnosed With Pediatric Low-Grade Gliomas: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database

R. Beroukhim, W. London, L. Goumnerova, 2014, Pediatric blood & cancer.

Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme

T. MacDonald, S. Vajapeyam, L. Goumnerova, 2007, Journal of Neuro-Oncology.

Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy

U. Girolami, L. Goumnerova, M. Kieran, 2008, Journal of Neuro-Oncology.

From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis

Karlyne M. Reilly, A. Lloyd, D. Evans, 2019, American journal of medical genetics. Part A.

Reproducibility of cognitive endpoints in clinical trials

Packer, G. Gioia, Michael Fisher, 2019 .

Practical guidance for telemedicine use in neuro-oncology

Jennie W. Taylor, R. Strowd, M. Mrugala, 2022, Neuro-oncology practice.

Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant

K. Krull, Stephanie J. Lee, N. Ullrich, 2020, Journal of Cancer Survivorship.

Protein Farnesylation inhibitors lonafarnib, Pravastatin, and Zoledronic acid in children With hutchinson-gilford Progeria syndrome

C. Gordon, B. Snyder, H. Shappell, 2016 .

Research during Pediatric Residency: Predictors and Resident-Determined Influences

N. Ullrich, H. Bernstein, P. Hibberd, 2003, Academic medicine : journal of the Association of American Medical Colleges.

NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY

F. Orge, G. Cutter, S. Stasheff, 2020, Neuro-Oncology.

Consensus Recommendations for Managing Childhood Cancer Survivors at Risk for Stroke After Cranial Irradiation

M. Hudson, T. Yock, N. Ullrich, 2022, Neurology.

BRAINSTEM LESIONS IN NEUROFIBROMATOSIS TYPE 1

L. Goumnerova, M. Kieran, N. Ullrich, 2007, Neurosurgery.

Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.

B. Korf, G. Cutter, A. Muzikansky, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Update from the 2013 international neurofibromatosis conference

Michael Fisher, A. Lloyd, A. Stemmer-Rachamimov, 2014, American journal of medical genetics. Part A.

Sixty years single institutional experience with pediatric craniopharyngioma: between the past and the future

R. Scott, L. Goumnerova, M. Kieran, 2019, Child's Nervous System.

Liver Failure as the Presentation of Ornithine Transcarbamylase Deficiency in a 13-Month-Old Female.

S. Waisbren, J. Soul, M. Jonas, 2018, JIMD reports.

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

D. Viskochil, E. Schorry, L. Klesse, 2020, The oncologist.

Sleep dysfunction in long term survivors of craniopharyngioma

L. Cohen, S. Pomeroy, W. London, 2012, Journal of Neuro-Oncology.

Transient global amnesia in a young adult with cyanotic heart disease.

N. Ullrich, D. Urion, 2003, Pediatric neurology.

Neurofibromatosis type 1-associated brain tumors

N. Ullrich, 2016 .

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.

B. Lange, N. Ullrich, S. Castellino, 2014, Journal of the National Cancer Institute.

Chapter 165 – Development of the Nervous System

S. Pomeroy, N. Ullrich, 2004 .

Health Supervision for Children With Neurofibromatosis Type 1

David T. Miller, B. Korf, D. Viskochil, 2019, Pediatrics.

Hutchinson-Gilford progeria syndrome.

N. Ullrich, L. Gordon, 2015, Handbook of clinical neurology.

Germinoma with malignant transformation to nongerminomatous germ cell tumor.

J. M. Wong, L. Goumnerova, M. Lechpammer, 2010, Journal of neurosurgery. Pediatrics.

Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study

Elizabeth M. Wells, A. King, G. Armstrong, 2016, Neuro-oncology.

Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

C. Ronckers, G. Armstrong, M. Hudson, 2021, The Lancet. Oncology.

The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research

B. Korf, S. Plotkin, N. Ullrich, 2021, Orphanet Journal of Rare Diseases.

Chapter 5 - Microarray Analysis and Proteomic Approaches to Drug Development

S. Pomeroy, N. Ullrich, 2006 .

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

E. Zackai, G. Mortier, David T. Miller, 2017, American journal of human genetics.

Functional outcome measures for NF1-associated optic pathway glioma clinical trials

D. Gutmann, L. Bilaniuk, Jeffrey C. Allen, 2013, Neurology.

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Uri Tabori, Joel Charrow, Eric Bouffet, 2012, Neuro-oncology.

Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1

L. Goumnerova, M. Kieran, A. Huttner, 2010, Pediatric blood & cancer.

PDCT-24. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS-RAF PATHWAY-ACTIVATED TUMORS: INITIAL REPORT

Mariella G. Filbin, T. MacDonald, K. Ligon, 2017 .

MEK Inhibitors for Neurofibromatosis Type 1 Manifestations: Clinical Evidence and Consensus.

M. Loh, Michael Fisher, K. Walsh, 2022, Neuro-oncology.

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Michael Fisher, A. Stemmer-Rachamimov, B. Korf, 2021, Genetics in Medicine.

Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.

Alan Cantor, John Perentesis, David H Gutmann, 2015, Neuro-oncology.

Sirolimus for progressive neuroﬁbromatosis type 1 – associated plexiform neuroﬁbromas: a Neuroﬁbromatosis Clinical Trials Consortium phase II study

Michael Fisher, B. Korf, D. Gutmann, 2015 .

Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study

G. Armstrong, K. Krull, L. Robison, 2020, Genetics in Medicine.

Late Morbidity and Mortality in Adult Survivors of Childhood Glioma with Neurofibromatosis Type 1: Report from the Childhood Cancer Survivor Study

G. Armstrong, K. Krull, L. Robison, 2020, Genetics in Medicine.

Molecular genetics of pediatric central nervous system tumors

S. Pomeroy, N. Ullrich, 2006, Current oncology reports.

Neurocutaneous Syndromes and Brain Tumors

N. Ullrich, 2016, Journal of child neurology.

Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria Syndrome

R. D'Agostino, C. Gordon, David T. Miller, 2016, Circulation.

Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome

A. Giobbie-Hurder, D. Neuberg, A. Schwartzman, 2012, Proceedings of the National Academy of Sciences.

Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs

Kevin B. Jones, P. Park, David T. Miller, 2020, Genes.

Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1

L. Goumnerova, M. Kieran, G. Heidary, 2016, Journal of Neuro-Oncology.

Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association With Adult Functional Outcomes

Y. T. Cheung, G. Armstrong, D. Srivastava, 2020, JNCI cancer spectrum.

Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

N. Zhang, D. Srivastava, K. Krull, 2013, Journal of Cancer Survivorship.

Calvarial defects and skeletal dysplasia in patients with neurofibromatosis Type 1.

M. Proctor, N. Ullrich, A. Danehy, 2013, Journal of neurosurgery. Pediatrics.

Peripheral neuropathy in children and adolescents treated for cancer.

W. Evans, M. Dolan, K. Ness, 2018, The Lancet. Child & adolescent health.

A Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for Recurrent, Radiographic-Progressive Neurofibromatosis Type 1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis Clinical Trials Consortium Study.

B. Korf, G. Cutter, S. Prabhu, 2020, Neuro-oncology.

Optimizing Postoperative Surveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns.

L. Goumnerova, N. Ullrich, H. Dasenbrock, 2020, Neurosurgery.

Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report

Elizabeth M. Wells, A. King, G. Armstrong, 2018, Neuro-oncology.

Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging.

Elizabeth A. Thompson, L. Goumnerova, M. Kieran, 2014, Journal of neurosurgery. Pediatrics.

Medical, psychological, cognitive and educational late‐effects in pediatric low‐grade glioma survivors treated with surgery only

L. Goumnerova, M. Kieran, N. Ullrich, 2009, Pediatric blood & cancer.

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Michael Fisher, B. Korf, G. Cutter, 2021, Nature Medicine.

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Steven P. Angus, B. Korf, G. Cutter, 2021, Nature Medicine.

CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies

Michael Fisher, B. Korf, J. Kissil, 2014, American journal of medical genetics. Part A.

Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma

Michael Fisher, R. Hoffman, J. Charrow, 2014, Annals of neurology.

“The choking game”: Self-induced hypoxia presenting as recurrent seizurelike events

H. Goodkin, A. Bergin, N. Ullrich, 2008, Epilepsy & Behavior.

Analysis of copy number variants in 11 pairs of monozygotic twins with neurofibromatosis type 1

T. Smolarek, L. Messiaen, D. Viskochil, 2017, American Journal of Medical Genetics. Part A.

Incidence, risk factors, and longitudinal outcome of seizures in long‐term survivors of pediatric brain tumors

K. Kapur, S. Pomeroy, T. Loddenkemper, 2015, Epilepsia.

Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1

Alcino J. Silva, G. Gioia, K. Walsh, 2016, Neurology.

Risk factors for chemotherapy‐induced nausea in pediatric patients receiving highly emetogenic chemotherapy

J. Krischer, K. Kelly, O. J. Sahler, 2019, Pediatric blood & cancer.

Vitamin B12 Deficiency Presenting with Neurological Dysfunction in an Adolescent.

N. Ullrich, Adam D. Durbin, R. Grace, 2016, Pediatric neurology.

Back pain and spinal cord compression: An uncommon presentation of childhood acute myeloid leukemia

N. Ullrich, J. Vergilio, B. Degar, 2011, Journal of Pediatric Neurology.

Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey

N. Ullrich, K. Hardy, C. Dvorak, 2020, Pediatric blood & cancer.

Long‐term clinical outcomes following treatment of childhood craniopharyngioma

D. Neuberg, L. Cohen, S. Pomeroy, 2011, Pediatric blood & cancer.

Children's Oncology Group's 2013 blueprint for research: Cancer control and supportive care

D. Johnston, N. Ullrich, T. Zaoutis, 2013, Pediatric blood & cancer.

A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.

K. Yeom, N. Ullrich, S. Partap, 2019, Pediatric neurology.

Outcomes after first relapse of childhood intracranial ependymoma

Mariella G. Filbin, D. Haas-Kogan, K. Wright, 2021, Pediatric blood & cancer.

Pediatric brain tumors.

S. Pomeroy, N. Ullrich, 2003, Neurologic clinics.

Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

M. Snuderl, J. Fangusaro, D. Haas-Kogan, 2017, Journal of Neuro-Oncology.

Myxopapillary ependymomas in children: imaging, treatment and outcomes

R. Beroukhim, K. Ligon, L. Goumnerova, 2015, Journal of Neuro-Oncology.

Brain tumors and epileptic spasms: Natural history and outcomes

L. Goumnerova, N. Ullrich, P. Manley, 2017, Epilepsy & Behavior.

Craniopharyngioma Therapy: Long-Term Effects on Hypothalamic Function

S. Pomeroy, R. Scott, N. Ullrich, 2005, The neurologist.

Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature

U. de Girolami, M. Proctor, S. Zacharoulis, 2016, Journal of pediatric hematology/oncology.

The Effectiveness of a Hospital-Based School Liaison Program: A Comparative Study of Parental Perception of School Supports for Children With Pediatric Cancer and Neurofibromatosis Type 1

W. London, A. Muriel, N. Ullrich, 2018, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

Parent-reported outcomes associated with utilization of a pediatric cancer school consultation program.

W. London, A. Muriel, N. Ullrich, 2016 .

Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1

K. Walsh, P. de Blank, N. Ullrich, 2021, Neurology.

Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1

K. Walsh, N. Ullrich, K. Hardy, 2022 .

Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma

L. Cohen, R. Scott, D. Zurakowski, 2020, Child's Nervous System.

Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth

N. Ullrich, C. Cacciotti, Tabitha Cooney, 2023, Journal of Neuro-Oncology.

Are Some Randomized Clinical Trials Impossible?

D. Viskochil, D. Stevenson, B. Widemann, 2020, Journal of pediatric orthopedics.

Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1

K. Walsh, M. Bellgrove, B. Korf, 2019, Journal of attention disorders.

Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1

K. Walsh, G. Cutter, K. North, 2020, Annals of clinical and translational neurology.

Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1

G. Gioia, K. Walsh, B. Korf, 2019, Annals of clinical and translational neurology.

Morning glory disc anomaly in association with ipsilateral optic nerve glioma.

L. Goumnerova, N. Ullrich, P. Bandopadhayay, 2012, Archives of ophthalmology.

Orbital Silicone Oil Granuloma Discovered During Enucleation

L. Goumnerova, N. Ullrich, P. Bandopadhayay, 2012 .

Acupressure bands do not improve chemotherapy‐induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single‐blinded, randomized controlled trial

J. Krischer, K. Kelly, O. J. Sahler, 2018, Cancer.

Children with segmental neurofibromatosis type 1 are at increased risk for academic and cognitive difficulties

N. Ullrich, C. Rey-Casserly, M. Irons, 2010, Journal of Pediatric Neurology.

Electroencephalographic correlate of juvenile Huntington's disease.

J. Riviello, N. Ullrich, E. Donner, 2004, Journal of child neurology.

A prospective, blinded analysis of A‐PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors

L. Goumnerova, M. Kieran, N. Ullrich, 2009, Pediatric blood & cancer.

Psychoactive medication use and neurocognitive function in adult survivors of childhood cancer: A report from the childhood cancer survivor study

N. Zhang, K. Krull, D. Green, 2013, Pediatric blood & cancer.

Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

N. Ullrich, N. Phillips, E. Duke, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cerebellar Mutism After Posterior Fossa Tumor Resection

N. Ullrich, L. Northman, A. Green, 2014, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

Neuro-oncology training for the child neurology resident.

S. Pomeroy, N. Ullrich, 2011, Seminars in pediatric neurology.

Association of Rapidly Progressive Moyamoya Syndrome With Bevacizumab Treatment for Glioblastoma in a Child With Neurofibromatosis Type 1

M. Kieran, N. Ullrich, K. Marcus, 2011, Journal of child neurology.

Bacillus cereus Cerebral Abscess During Induction Chemotherapy for Childhood Acute Leukemia

N. Ullrich, G. Dabscheck, L. Silverman, 2015, Journal of pediatric hematology/oncology.

Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment

Donna Neuberg, Nicole J. Ullrich, David T. Miller, 2013, Neurology.

Pain affect disrupted in children with posterior cerebellar tumor resection

E. Moulton, N. Ullrich, P. Manley, 2019, Annals of clinical and translational neurology.

School liaison program supporting children with neurofibromatosis type 1: a model of care for children with chronic disease

David T. Miller, N. Ullrich, M. A. Chambers, 2018, Genetics in medicine : official journal of the American College of Medical Genetics.

LONG-TERM EFFICACY AND TOXICITY OF BEVACIZUMAB-BASED THERAPY IN CHILDREN WITH RECURRENT LOW-GRADE GLIOMAS

D. Ben-Bashat, M. Yalon, S. Constantini, 2012 .

The Impact of Intraoperative Electrocorticography on Seizure Outcome After Resection of Pediatric Brain Tumors: A Cohort Study.

L. Goumnerova, N. Ullrich, P. Manley, 2018, Neurosurgery.

A single‐institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors

C. Weldon, C. Rodríguez-Galindo, W. London, 2023, Cancer medicine.

Management of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas.

Michael Fisher, G. Harris, M. Bredella, 2022, Neuro-oncology.

Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children

B. Korf, S. Prabhu, D. Gutmann, 2020, Pediatric blood & cancer.

Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy

K. White, E. Schorry, V. Staedtke, 2023, Journal of pediatric orthopedics.

Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1‐associated optic pathway gliomas in children

B. Korf, S. Prabhu, D. Gutmann, 2020, Pediatric blood & cancer.

Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists

S. Plotkin, N. Ullrich, V. Merker, 2021, Orphanet Journal of Rare Diseases.

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation

Michael F. Wangler, David T. Miller, B. Korf, 2018, Genetics in Medicine.

Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma

Michael Fisher, B. Korf, J. Tonsgard, 2023, Neuro-oncology.

Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotypeâ€“phenotype correlation

Michael F. Wangler, David T. Miller, B. Korf, 2019 .

LGG-44. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS/RAF PATHWAY-ACTIVATED TUMORS

K. Ligon, R. Sposto, M. Borchert, 2018, Neuro-Oncology.

Children’s at Home: Pilot Study Assessing Dedicated Social Media for Parents of Adolescents with Neurofibromatosis Type 1

M. Rich, C. Akré, J. Polvinen, 2018, Journal of Genetic Counseling.

Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1

Michael Fisher, L. Klesse, S. Plotkin, 2023, Clinical trials.

75 – Other Acquired Epilepsies: Trauma, Stroke, Tumors

H. Goodkin, N. Ullrich, R. Bailey, 2017 .

Guidance for the Clinician in Rendering Pediatric Care Health Supervision for Children With Neuro fi bromatosis Type 1

E. Schorry, N. Ullrich, D. Freedenberg, 2019 .

Hutchinson-Gilford progeria syndrome.

N. Ullrich, L. Gordon, 2015, Handbook of clinical neurology.

The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis

A. Lloyd, A. Stemmer-Rachamimov, J. Kissil, 2017, American journal of medical genetics. Part A.

Title The path forward : 2015 International Children ' s Tumor Foundation conference on neurofibromatosis type 1 , type 2 , and schwannomatosis Permalink

A. Lloyd, A. Stemmer-Rachamimov, J. Kissil, 2017 .

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA

I. Cortés-Ciriano, A. Feber, M. Snuderl, 2022, bioRxiv.

Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma

Michael Fisher, R. Hoffman, J. Charrow, 2014, Annals of Neurology.

Cerebral Vasculopathy in Children with Neurofibromatosis Type 1

N. Ullrich, Laura L. Lehman, 2023, Cancers.

LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study

T. MacDonald, N. Agar, M. Kieran, 2022, Neuro-Oncology.

Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study.

G. Armstrong, D. Srivastava, K. Krull, 2018 .